Guidance Capital Inc. Invests $724,000 in Astrana Health, Inc. (NASDAQ:ASTH)

Guidance Capital Inc. acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, Holdings Channel reports. The fund acquired 11,943 shares of the company’s stock, valued at approximately $724,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ASTH. GAMMA Investing LLC bought a new position in Astrana Health during the 3rd quarter valued at about $34,000. Central Pacific Bank Trust Division acquired a new stake in Astrana Health in the 3rd quarter valued at about $160,000. Everence Capital Management Inc. acquired a new stake in Astrana Health in the 3rd quarter valued at about $272,000. Granite Bay Wealth Management LLC acquired a new stake in Astrana Health in the 3rd quarter valued at about $290,000. Finally, Handelsbanken Fonder AB acquired a new stake in Astrana Health in the 3rd quarter valued at about $492,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Stock Down 1.6 %

Shares of ASTH stock traded down $0.93 during trading on Wednesday, reaching $56.97. The company’s stock had a trading volume of 16,934 shares, compared to its average volume of 196,894. The business has a fifty day moving average price of $53.62 and a 200-day moving average price of $46.13. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The company has a market cap of $3.19 billion, a price-to-earnings ratio of 43.86, a price-to-earnings-growth ratio of 2.20 and a beta of 1.21. Astrana Health, Inc. has a one year low of $28.86 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $486.30 million for the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The firm’s revenue for the quarter was up 39.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.28 earnings per share. Analysts anticipate that Astrana Health, Inc. will post 1.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ASTH. Robert W. Baird lifted their price target on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research report on Thursday, August 15th. Stifel Nicolaus lifted their price target on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. KeyCorp initiated coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. TD Cowen initiated coverage on shares of Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 price objective on the stock. Finally, Truist Financial lifted their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $62.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.